Trachoma Prevalence After Discontinuation of Mass Azithromycin Distribution

BACKGROUND: As the World Health Organization seeks to eliminate trachoma by 2020, countries are beginning to control the transmission of trachomatous inflammation–follicular (TF) and discontinue mass drug administration (MDA) with oral azithromycin. We evaluated the effect of MDA discontinuation on...

Descripción completa

Detalles Bibliográficos
Autores principales: Godwin, William, Prada, Joaquin M, Emerson, Paul, Hooper, P J, Bakhtiari, Ana, Deiner, Michael, Porco, Travis C, Mahmud, Hamidah, Landskroner, Emma, Hollingsworth, T Déirdre, Medley, Graham F, Pinsent, Amy, Bailey, Robin, Lietman, Thomas M, Oldenburg, Catherine E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Supplement Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289551/
https://www.ncbi.nlm.nih.gov/pubmed/32052842
http://dx.doi.org/10.1093/infdis/jiz691

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289551/
https://www.ncbi.nlm.nih.gov/pubmed/32052842
http://dx.doi.org/10.1093/infdis/jiz691

Ejemplares similares